Vein crawling mini robot developed

  • 22 July 2009

The ViRob prototype

The Israeli Institute of Technology has created a miniature crawling robot small enough to crawl through human veins.

The robot has been developed to perform precise medical procedures in the human body to potentially diagnose and treat artery blockage and cancer.

Researchers at the Technicon institute have so far developed a basic prototype of the ViRob, which is just 1mm wide and 12mm long but is able to move as fast as 9mm per second.

They are examining the possibility of using the robot as a treatment for lung cancer by using it to assist targeted drug delivery to lung tumours and for taking different samples from parts of the body.

Professor Moshe Shoham, leader of the Technicon researchers and head of the Kahn Medical Robotics Laboratory at the institute, said: “This robot is a breakthrough in the biomedical industry, as it allows doctors to access inaccessible areas in the body with minimal invasion.

“The technology enables targeted treatment without scattering materials to unnecessary areas in the body.”

The ViRob has tiny arms that allow it to stabilise against blood pressure and allow it to crawl through the inner walls of blood vessels, the digestive tract and the respiratory to the veins and then arteries.

It is powered by an external magnetic field, which allows it to be controlled for long periods of time during procedures.

The researchers are now planning to install additional equipment on the robot such as electrodes and miniature drug capsules to treat a number of diseases.

Link

Israel Institute of Technology

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

AI smart mirror project launched for young cancer survivors

AI smart mirror project launched for young cancer survivors

A Ā£5m research project is aiming to improve the long-term cardiovascular health of young cancer survivors through an AI powered smart mirror.
Gemma Peters: ‘AI could make a huge difference when it comes to cancer’

Gemma Peters: ‘AI could make a huge difference when it comes to cancer’

It's not the pace of innovation that limits us, but how society harnesses these advances, says Gemma Peters, chief executive of Macmillan
Government launches AI breast cancer trial

Government launches AI breast cancer trial

The government has announced the launch of a trial that will test how AI tools can be used to detect cases of breast cancer earlier.